Kaneka gears up for proprietary probiotic Floradapt launch

The new product line will officially launch at SupplySide West

Kaneka Americas Holding is set to launch Floradapt, a new proprietary probiotic line, and has joined forces with marketing specialist BrandHive to implement the strategic move into the marketplace.

The new Floradapt line will officially launch at SupplySide West this year and offers distinct solutions for diverse health targets such as children’s colic, cardio, digestive, oral, immune, vaginal and urinary tract fields.

According to Kaneka, Floradapt’s unique clinical strains provide highly bioefficacious effects for specific health applications through all stages of life.

Commenting on the partnership, Mike Kolifrath, Vice President of the Probiotics Division, said: “Our strategic collaboration with BrandHive will elevate our outreach and generate awareness of our new probiotic line, Floradapt. BrandHive has extensive knowledge and experience in the dietary supplements arena, and we are looking forward to optimizing our footprint and engaging with customers and partners in greater depth.”

Kaneka has a bank of more than 1,000 clinical probiotic strains extracted from human origin and fermented food samples that have not been affected by western lifestyle, diet or medicine.

“We are excited to represent Kaneka who has a rich history within the industry and is known as a leader in the research and development of scientifically based ingredients,” said Andy Yorkin, Account Director at BrandHive. “We look forward to supporting their growth in North America for this unique and innovative line of probiotics.”

Companies